内科学心力衰竭范维琥课件.ppt

上传人:牧羊曲112 文档编号:1462112 上传时间:2022-11-28 格式:PPT 页数:30 大小:984KB
返回 下载 相关 举报
内科学心力衰竭范维琥课件.ppt_第1页
第1页 / 共30页
内科学心力衰竭范维琥课件.ppt_第2页
第2页 / 共30页
内科学心力衰竭范维琥课件.ppt_第3页
第3页 / 共30页
内科学心力衰竭范维琥课件.ppt_第4页
第4页 / 共30页
内科学心力衰竭范维琥课件.ppt_第5页
第5页 / 共30页
点击查看更多>>
资源描述

《内科学心力衰竭范维琥课件.ppt》由会员分享,可在线阅读,更多相关《内科学心力衰竭范维琥课件.ppt(30页珍藏版)》请在三一办公上搜索。

1、1,Heart failure,2,DEFINITION,HEART FAILURE A clinical syndrome in which an abnormality of cardiac structure or function is responsible for the inability of the heart to eject or fill with blood at a rate commensurate with the requirements of the metabolizing tissues. Heart failure results in a const

2、ellation of clinical manifestations, including circulatory congestion, dyspnea, fatigue, and weakness.,3,FORMS OF HEART FAILURE,Systolic vs diastolic heart failure Low-output vs high-output heart failure Acute vs chronic heart failure Right-sided vs left-sided heart failure,4,UNDERLYING CAUSES,Ische

3、mic heart diseaseCardiomyopathiesCongenital, valvular and hypertensive heart disease (potential treatable ),5,PRECIPITATING FACTORS,InfectionArrhythmiasPhysical, dietary, fluid, environmental, and emotional excessesMyocardial infarctionPulmonary embolism AnemiaThyrotoxicosis and pregnancyAggravation

4、 of hypertensionRheumatic, viral, and other forms of myocarditisInfective endocarditis,6,PATHOGENESIS,Chronic hemodynamic overloadeccentric ventricular hypertrophy Chronic pressure overload concentric ventricular hypertrophy Ventr. hypertrophy ventr. DilatationRemodeling of ventricle HFActivation of

5、 endogenous neurohormonal system and cytokines,7,“,8,CLINICAL MANIFESTATION OF HF,Primary Symptoms Dyspnea Orthopnea Paroxysmal (nocturnal) dyspnea Acute pumnonary edema,9,CLINICAL MANIFESTATION OF HF,Other symptomsFatigue and weaknessAbdominal symptomsCerebral symptoms,10,PHYSICAL FINDINGS OF HF,Ge

6、neral findingsPulse pressure (severe HF) SBP with cool, diaphoretic extremities, and Cheyne -Stokes respirationCyanosis, sinus tachycardia,11,PHYSICAL FINDINGS OF HF,Cardiovascular findings S3 and S4 Cardiomegaly Murmurs Pulsus alternans Distention of j v. (systemic v. p),12,PHYSICAL FINDINGS OF HF,

7、Pulmonary ralesCardiac edemaSymmetric and dependent in the legsMost prominet in eveningHydrothorax and ascitesCongestive hepatomegaly.,13,LABORATORY EXAMINATION,N-terminal-pro-BNP and BNPTwo-dimensioanl echocardiography with Doppler flow studiesChest roentgenogramECG,14,Echocardiogram,2D echo with D

8、opler technique for systolic and diastolic function of LV LVDd and LVDs(Dd and Ds)LVEF,15,DIAGNOSIS OF HF,Combination of the clinical manifestation of HF, together with the findings characteristic of one of the underlying forms of heart disease.,16,DIFF. DIAGNOSIS OF HF,Pulmonary diseasePulmonary em

9、bolismAnkle edemaEnlargement of the liver and ascites,17,TREATMENT OF HF,Correction of the underlying causeRemoval of the precipitating causePrevention of deterioration of cardiac functionControl of the congestive HF state,GENERAL MEASURES,Treating coronary risk factors Moderate dietary Na restricti

10、on Daily measurement of weight Prevent respiratory infection Avioding excessive alcohol, temperature extremes, and tiring trips,19,TREATMENT OF HF,Control of excessive fluidDietDiureticsThiazide diureticsMetolazoneFrusemideBumetanidetorsemidePotassium-sparing diuretics,20,TREATMENT OF HF,Blockade of

11、 renin-angiotensin-aldosterone and adrenergic systemACE inhibitorsAngiotensin receptor blockersBeta-adrenoceptor blockersAldosterone antagonist,21,TREATMENT OF HF,Enhancement of myocardial contractilityDigitalisSympathomimetic aminesPhosphodiesterase inhibitors,22,TREATMENT OF HF,VasodilatorsNitrate

12、sNitroglycerineIsosorbide dinitrateMononitratesNitroprussidenesiritide,23,TREATMENT OF HF,Ventricular resynchronizationManagement of arrhythmiaAnticoagulantsRefractory heart HFAssisted circulation/cardiac transplant.,24,STAGE A,At high risk for HF but without structural heart disease or symptoms of

13、HF.Treat hypertensionEncourage smoking cessationTreat lipid disordersEncourage regular exerciseDiscourage alcohol intake, illicit drug useControl metabolic syndromeACEI or ARB in appropriate patients for vascular disease or diabetes,25,STAGE B,Structural heart disease but without signs or symptoms o

14、f HFAll measures under Stage AACEI or ARB in appropriate patients Beta-blockers in appropriate patients,26,STAGE C,Structural heart disease with prior or current symptoms of HF.All measures under Stages A and BDietary salt restrictionDRUGS FOR ROUTINE USEDiuretics for fluid retentionACEIBeta-blocker

15、sDRUGS IN SELECTED PATIENTSAldosterone antagonistARBsDigitalisHydralazine/nitratesDEVICES IN SELECTED PATIENTSBiventricular pacingImplantable defibrillators,27,STAGE D,Refractory HF requiring specialized interventions.Appropriate measures under Stages A, B, CDecision re: appropriate level of careOPT

16、IONSCompassionate end of-life care/hospiceExtraordinary measuresheart transplantchronic inotropespermanentmechanical supportexperimentalsurgery or drugs,28,PROGNOSIS OF HF,Depend on Nature of the underlying heart disease Presence of a treatable precipitating factorThe response to treatment,谢 谢,docin/sanshengshiyuandoc88/sanshenglu,更多精品资源请访问,

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 生活休闲 > 在线阅读


备案号:宁ICP备20000045号-2

经营许可证:宁B2-20210002

宁公网安备 64010402000987号